NextCure hires Cel­gene vet as CMO; José Ve­ga leaves Mer­ck to be­come Mod­er­na's chief safe­ty of­fi­cer

NextCure has found its new CMO af­ter the pre­vi­ous ex­ec­u­tive re­signed last Au­gust.

Han Myint, a bio­phar­ma and acad­e­mia vet­er­an of more than 20 years, joined the com­pa­ny Thurs­day af­ter serv­ing as CMO at Nex­Im­mune for a lit­tle over a year. Myint had over­seen the com­pa­ny’s Phase I/II tri­al for a cell ther­a­py in acute myeloid leukemia be­fore hop­ping over to NextCure.

“Han’s strong in­dus­try track record is high­light­ed by his in­volve­ment in the de­vel­op­ment of mul­ti­ple U.S. Food and Drug ap­proved prod­ucts,” CEO Michael Rich­man said in a state­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER